the vaccine – Page 35 – Communicable Diseases Research

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

단일 용량 Ad26.COV2.S의 효능 및 안전성에 대한 최종 분석

Clinical Trial

Published on 2022-03-032022-09-11
Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 변종, 임상,

Assessment of Clinical Effectiveness of BNT162b2 COVID-19 Vaccine in US Adolescents

미국 청소년에 대한 BNT162b2 COVID-19 백신의 임상 효과 평가

Research

Published on 2022-03-032022-09-10
Journal: JAMA Network Open [Category] MERS, SARS, 변종,

[키워드] 95% CI Adolescent age assessment association asymptomatic infection B.1.617.2 black BNT162b2 BNT162b2 vaccine case-control study caused Chain Reaction clinical Clinical data Clinical symptoms clinical trial conducted Connecticut Control COVID-19 COVID-19 vaccine defined Delta delta variant dose doses effective Effectiveness elapsed estimate exposure female Final finding General population Hispanic Hospitalization hospitalizations immunization immunized Importance Increases increases in Infection IQR logistic regression models matched control measure median age median time medical record medical records negative test New objective Odds ratio of BNT162b2 participant Participants Point positive test result predominant Primary outcome receiving Relevance residence Result retrospective RT-PCR RT-PCR test SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 positivity SARS-CoV-2 test secondary setting single dose symptomatic and asymptomatic symptomatic infection symptomatic infections test result test results tested the SARS-CoV-2 the vaccine Vaccine vaccine dose vaccine doses variant of SARS-CoV-2 white
[DOI] 10.1001/jamanetworkopen.2022.0935 PMC 바로가기 [Article Type] Research

Dynamical regulations on mobility and vaccinations for controlling COVID-19 spread

Covid-19 스프레드 제어를위한 이동성 및 예방 접종에 대한 동적 규정

Article

Published on 2022-03-032022-09-10
Journal: Scientific Reports [Category] MERS, SARS, 변종,

[키워드] country COVID-19 Critical decrease disease transmission Diseases document dropping Effectiveness explain Forecasting further Infectious diseases prototype Regulation reproductive required Spread the vaccine the vaccines Transmission vaccination variants
[DOI] 10.1038/s41598-022-07371-5 PMC 바로가기 [Article Type] Article

Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant

비활성화 기반 COVID-19 백신의 3회 용량은 SARS CoV-2 Omicron 변이체에 대한 교차 중화 면역을 유도합니다

Coronaviruses

Published on 2022-03-032022-09-10
Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 B.1.1.529 collected coronavirus COVID-19 vaccine cross-neutralizing delta variant demonstrated dose enrolled fold geometric mean geometric mean titer geometric mean titers GMT immune Immunity immunization immunized induce natural infection neutralization activity Neutralizing activity neutralizing antibody omicron Omicron variant positive prototype pseudotyped Pseudotyped virus recipient reported respiratory SARS CoV SARS CoV-2 SARS-CoV-2 sera serum sample serum samples severe acute respiratory syndrome Coronavirus sustained the vaccine vaccination Vaccine variant was determined
[DOI] 10.1080/22221751.2022.2044271 PMC 바로가기 [Article Type] Coronaviruses

Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia

Research Article

Published on 2022-03-032022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

Management of COVID-19 vaccines cold chain logistics: a scoping review

Review

Published on 2022-03-022022-10-29
Journal: Journal of Pharmaceutical Policy and Practice [Category] COVID-19,

Longitudinal changes in COVID-19 vaccination intent among South African adults: evidence from the NIDS-CRAM panel survey, February to May 2021

남아프리카 성인의 Covid-19 백신 접종 의도의 종단 변화 : 2021 년 2 월부터 5 월까지 NIDS-CRAM 패널 조사의 증거

Research

Published on 2022-03-022022-09-01
Journal: BMC Public Health [Category] MERS, SARS, 진단,

[키워드] 95% CI Adults African age aggregate analysed Analysis change changes in concern conducted coronavirus country COVID-19 COVID-19 vaccination COVID-19 vaccine Cross-sectional analyses cross-sectional analysis demographic groups determinant determinants Dynamics Evidence examined Formal Frame Hesitancy income indicated information longitudinal longitudinal change longitudinal changes Longitudinal data make up male media Mobile National norm pandemic Panel survey percentage points predictor proportion public health Rapid receive remained Result significantly increased social media South South Africa supplementary material survey the vaccine the vaccines translate vaccination Vaccine Vaccine acceptance Vaccine hesitancy Variation Wave Waves
[DOI] 10.1186/s12889-022-12826-5 PMC 바로가기 [Article Type] Research

Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment

항-CD20 단일클론항체는 치료 후 6개월 이내에 비호지킨 림프종 환자에서 Covid-19 예방접종에 대한 혈청양성 반응을 억제합니다

Article

Published on 2022-03-012022-09-12
Journal: Experimental hematology [Category] MERS, SARS, 진단, 치료법,

Rolling Reviews During COVID-19: The European Union Experience in a Global Context

Covid-19의 롤링 리뷰 : 글로벌 맥락에서 유럽 연합 경험

Article

Published on 2022-03-012022-08-31
Journal: Clinical therapeutics [Category] MERS, 신약개발,

[키워드] accelerate added addressed applied approach approval approved as required benefit capture collected complement conducted Context COVID-19 COVID-19 pandemic COVID-19 vaccine COVID-19 vaccines critical condition disease dynamic regulatory assessment effective Efficiency EMA European European Medicines Agency example expedited approval pathways experience faster focus globe Health authority health emergency help indicate information Intensive learning life-threatening literature medical need not limited offered Other pandemic Patient Regulatory required resource review Rolling rolling review Society submitted the vaccine the vaccines Treatment union unmet need Unmet Needs Vaccine Vaccines website
[DOI] 10.1016/j.clinthera.2022.01.001 PMC 바로가기 [Article Type] Article

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

만성 림프구성 백혈병 환자에서 BNT162b mRNA COVID-19 백신의 안전성 및 효능

Article

Published on 2022-03-012022-09-11
Journal: Haematologica [Category] MERS, SARS, 진단, 치료기술,

[키워드] a BTK inhibitor adverse event age Analysis anti-CD20 antibodies antibody Antibody Response BCl2 BNT162b BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine BTK inhibitor CD20 chronic lymphocytic leukemia CLL CLL patients Cohort Combination Concordance COVID-19 vaccine develop disease Efficacy eligible hemoglobin humoral IgA IgG IgM immune response individuals introduced investigated leukemia Lymphocytic leukemia monotherapy mRNA Neutralizing antibodies neutralizing antibody nine parameter Patient patients patients treated positive predict response response to vaccination Safe Safety second dose serological response Spike protein the vaccine treated treated patients Treatment treatment with anti-CD20 Vaccine
[DOI] 10.3324/haematol.2021.279196 PMC 바로가기 [Article Type] Article